Just weeks after Alere Inc. agreed to produce documents related to three government probes of its business, Abbott Laboratories said it has filed suit in the Delaware Court of Chancery seeking to terminate its $5.8 billion purchase of the health care diagnostics company.
Abbott announced the complaint on Wednesday, citing “substantial loss” to Alere’s value in the 10 months since the companies agreed to merge in January 2016.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]